Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Generation of Xeroderma Pigmentosum-A Patient-Derived Induced Pluripotent Stem Cell Line for Use As Future Disease Model.

Cellular reprogramming - 1 Aug 2015

Ohnishi Hiroe, Kawasaki Takashi, Deguchi Tomonori, Yuba Shunsuke

Abstract excerpt

Xeroderma pigmentosum group A (XP-A) is a genetic disorder in which there is an abnormality in nucleotide excision repair that causes hypersensitivity to sunlight and multiple skin cancers. The development of central and peripheral neurological disorders not correlated to ultraviolet light exposure is associated with XP-A. The genes responsible for XP-A have been identified and a XPA knockout mouse has been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line
Share to Cellular Reprogramming
Share to Fibroblasts

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Induced Pluripotent Stem Cells

Share to Xeroderma Pigmentosum

Share to Xeroderma Pigmentosum Group A Protein

Source

Identifiers

PMID: 26090552
DOI: 10.1089/cell.2014.0104

Genes

XPA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Generation of Xeroderma Pigmentosum-A Patient-Derived Induced Pluripotent Stem Cell Line for Use As Future Disease Model.PMID 26090552Read ↗

Modeling xeroderma pigmentosum associated neurological pathologies with patients-derived iPSCs.Semantic proximity Read ↗

Generation of two human iPSC lines, HMGUi004-A and FINCBi004-A, from fibroblasts of MPAN patients carrying pathogenic recessive mutations in the gene C19orf12.Semantic proximity Read ↗

Differences in Peripheral Neuropathy in Xeroderma Pigmentosum Complementation Groups A and DSemantic proximity Read ↗

Neurological manifestations of xeroderma pigmentosum due to XPA gene mutation.Semantic proximity Read ↗

Neural Differentiation of Human Pluripotent Stem Cells for Nontherapeutic Applications: Toxicology, Pharmacology, andIn VitroDisease ModelingSemantic proximity Read ↗

Generation of XPA p.Arg228T mutant LUMCi004-A cell line for modeling Xeroderma pigmentosum group A.Semantic proximity Read ↗

A rare genetic disorder provides insights into mechanisms of early-onset neurodegenerationSemantic proximity Read ↗

Establishment and characterization of human induced pluripotent stem cell line from a Parkinson's disease patient harboring VPS13A gene mutation.Semantic proximity Read ↗

Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.Semantic proximity Read ↗

Prospect of Human Pluripotent Stem Cell‐Derived Neural Crest Stem Cells in Clinical ApplicationSemantic proximity Read ↗

[Xeroderma pigmentosum].Semantic proximity Read ↗

Establishment of an iPSC line (BCHNDi001-A) from a patient with nicotinamide nucleotide repair system deficiency caused by biallelic NAXD mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.